The combined MEK and CDK4/6 inhibition induced tumour senescence and SASP‐driven endothelial cell activation, fostering the accumulation of CD8+ T cells and rendering tumours more responsive to PD‐1 checkpoint blockade.50 This evidence concerns the gene CD8A and neoplasm.